By Elric Langton | Tuesday 6th July 2021
Long term holding OptiBiotix Health Plc (OPTI), which is developing compounds to tackle obesity, high cholesterol, diabetes and skincare, has entered an exclusive distribution deal with the Republic of Korea base Inscobee.
As expected, the news was sold into yet again, as per norm. Initially, the shares were up β¦